Health
Moffitt researchers use mathematical modeling to help explain outcomes of CAR T-cell therapy – News-Medical.Net
Chimeric antigen receptor T-cell therapy, or CAR T, is a relatively new type of therapy approved to treat several types of aggressive B cell leukemias and lymphomas….
Chimeric antigen receptor T-cell therapy, or CAR T, is a relatively new type of therapy approved to treat several types of aggressive B cell leukemias and lymphomas. Many patients have strong responses to CAR T; however, some have only a short response and develop disease progression quickly. Unfortunately, it is not completely understood why these patients have progression. In an article published in Proceedings of the Royal Society B, Moffitt Cancer Center researchers use mathematical modeling…
-
Noosa News24 hours agoAFL live updates: Gold Coast vs Essendon – blog, scores and stats
-
Noosa News23 hours agoTwo-time Archibald Prize-winning painter William Robinson has died, aged 89
-
Noosa News23 hours agoWilliam Robinson dies aged 89
-
General22 hours agoCalls for corruption probe into completion of mayor’s Surfers Paradise Bowls Club site purchase